These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 9412302)
1. The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer. Sellers TA; Mink PJ; Cerhan JR; Zheng W; Anderson KE; Kushi LH; Folsom AR Ann Intern Med; 1997 Dec; 127(11):973-80. PubMed ID: 9412302 [TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study. Gapstur SM; Morrow M; Sellers TA JAMA; 1999 Jun; 281(22):2091-7. PubMed ID: 10367819 [TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality. O'Meara ES; Rossing MA; Daling JR; Elmore JG; Barlow WE; Weiss NS J Natl Cancer Inst; 2001 May; 93(10):754-62. PubMed ID: 11353785 [TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy and mortality in 52- to 70-year-old women: the Kuopio Osteoporosis Risk Factor and Prevention Study. Pentti K; Honkanen R; Tuppurainen MT; Sandini L; Kröger H; Saarikoski S Eur J Endocrinol; 2006 Jan; 154(1):101-7. PubMed ID: 16381998 [TBL] [Abstract][Full Text] [Related]
5. Breast cancer and hormone-replacement therapy in the Million Women Study. Beral V; Lancet; 2003 Aug; 362(9382):419-27. PubMed ID: 12927427 [TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy and some risk factors for breast cancer among Slovenian postmenopausal women. Cerne JZ; Ferk P; Leskosek B; Gersak K Climacteric; 2011 Aug; 14(4):458-63. PubMed ID: 21294673 [TBL] [Abstract][Full Text] [Related]
7. Breast Cancer Incidence and Mortality in Relation to Hormone Replacement Therapy Use Among Postmenopausal Women: Results From a Prospective Cohort Study. Jiang Y; Xie Q; Chen R Clin Breast Cancer; 2022 Feb; 22(2):e206-e213. PubMed ID: 34548240 [TBL] [Abstract][Full Text] [Related]
8. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001 [TBL] [Abstract][Full Text] [Related]
9. Population attributable risk of modifiable risk factors associated with invasive breast cancer in women aged 45-69 years in Queensland, Australia. Wilson LF; Page AN; Dunn NA; Pandeya N; Protani MM; Taylor RJ Maturitas; 2013 Dec; 76(4):370-6. PubMed ID: 24113278 [TBL] [Abstract][Full Text] [Related]
10. [Estrogen replacement therapy and breast cancer]. Bakken K; Alsaker E; Eggen AE; Lund E Tidsskr Nor Laegeforen; 2005 Feb; 125(3):282-5. PubMed ID: 15702147 [TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and breast cancer risk in a nationally representative cohort. Lando JF; Heck KE; Brett KM Am J Prev Med; 1999 Oct; 17(3):176-80. PubMed ID: 10987632 [TBL] [Abstract][Full Text] [Related]
12. Breast cancer incidence and hormone replacement therapy: results from the MISSION study, prospective phase. Espié M; Daures JP; Chevallier T; Mares P; Micheletti MC; De Reilhac P Gynecol Endocrinol; 2007 Jul; 23(7):391-7. PubMed ID: 17701770 [TBL] [Abstract][Full Text] [Related]
13. Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy. Manjer J; Malina J; Berglund G; Bondeson L; Garne JP; Janzon L Int J Cancer; 2001 Jun; 92(6):919-22. PubMed ID: 11351317 [TBL] [Abstract][Full Text] [Related]
14. A population-based cohort study of HRT use and breast cancer in southern Sweden. Olsson H; Bladström A; Ingvar C; Möller TR Br J Cancer; 2001 Sep; 85(5):674-7. PubMed ID: 11531250 [TBL] [Abstract][Full Text] [Related]
15. [Hormone replacement therapy and cancer of the breast. 1. Does replacement therapy increase the risk of cancer of the breast?]. Ayres de Campos D; Barros H; Martinez de Oliveira J Acta Med Port; 1997 Oct; 10(10):697-703. PubMed ID: 9477595 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT). Sourander L; Rajala T; Räihä I; Mäkinen J; Erkkola R; Helenius H Lancet; 1998 Dec 19-26; 352(9145):1965-9. PubMed ID: 9872245 [TBL] [Abstract][Full Text] [Related]
17. Factors modifying the association between hormone-replacement therapy and breast cancer risk. Pesch B; Ko Y; Brauch H; Hamann U; Harth V; Rabstein S; Pierl C; Fischer HP; Baisch C; Justenhoven C; Ranft U; Brüning T Eur J Epidemiol; 2005; 20(8):699-711. PubMed ID: 16151884 [TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy and high S phase in breast cancer. Cobleigh MA; Norlock FE; Oleske DM; Starr A JAMA; 1999 Apr; 281(16):1528-30. PubMed ID: 10227323 [TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study. Tjønneland A; Christensen J; Thomsen BL; Olsen A; Overvad K; Ewertz M; Mellemkjaer L Cancer; 2004 Jun; 100(11):2328-37. PubMed ID: 15160335 [TBL] [Abstract][Full Text] [Related]
20. Postmenopausal hormone replacement therapy: effect on diagnosis and outcome in early-stage invasive breast cancer treated with conservative surgery and radiation. Fowble B; Hanlon A; Freedman G; Patchefsky A; Kessler H; Nicolaou N; Hoffman J; Sigurdson E; Boraas M; Goldstein L J Clin Oncol; 1999 Jun; 17(6):1680-8. PubMed ID: 10561204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]